genworth financial inc. - GNW
GNW
Close Chg Chg %
8.38 -0.14 -1.67%
Open Market
8.24
-0.14 (1.67%)
Volume: 1.37M
Last Updated:
Jan 20, 2026, 1:46 PM EDT
Company Overview: genworth financial inc. - GNW
GNW Key Data
| Open $8.22 | Day Range 8.21 - 8.38 |
| 52 Week Range 5.99 - 9.28 | Market Cap $3.35B |
| Shares Outstanding 399.38M | Public Float 390.80M |
| Beta 1.07 | Rev. Per Employee N/A |
| P/E Ratio 15.87 | EPS $0.53 |
| Yield 0.00% | Dividend $0.10 |
| EX-DIVIDEND DATE Oct 8, 2008 | SHORT INTEREST N/A |
| AVERAGE VOLUME 3.76M |
GNW Performance
| 1 Week | 0.00% | ||
| 1 Month | -8.62% | ||
| 3 Months | -1.99% | ||
| 1 Year | 19.71% | ||
| 5 Years | 169.45% |
GNW Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
1
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | HOLD | Average Target Price | 10.00 | |
| Number of Ratings | 1 | Current Quarters Estimate | 0.16 | |
| FY Report Date | 12 / 2025 | Current Year's Estimate | 0.61 | |
| Last Quarter’s Earnings | 0.04 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 0.62 | Next Fiscal Year Estimate | 0.64 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 1 | N/A | 1 | 1 |
| Mean Estimate | 0.16 | N/A | 0.61 | 0.64 |
| High Estimates | 0.16 | N/A | 0.61 | 0.64 |
| Low Estimate | 0.16 | N/A | 0.61 | 0.64 |
| Coefficient of Variance | N/A | N/A | N/A | N/A |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 0 | 0 | 1 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 1 | 1 | 1 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Hold | Hold | Overweight |
SEC Filings for Genworth Financial Inc. - GNW
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Genworth Financial Inc. - GNW
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Mar 3, 2025 | Gregory S. Karawan EVP and General Counsel | 75,949 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Andrea Lynn White Pres. & CEO, CareScout Ins. | 642,101 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $6.65 per share | 4,269,971.65 |
| Mar 3, 2025 | Andrea Lynn White Pres. & CEO, CareScout Ins. | 648,638 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 3, 2025 | Andrea Lynn White Pres. & CEO, CareScout Ins. | 43,432 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 3, 2025 | Andrea Lynn White Pres. & CEO, CareScout Ins. | 56,259 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Melissa Hagerman EVP and Chief HR Officer | 70,323 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Melissa Hagerman EVP and Chief HR Officer | 43,432 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 3, 2025 | Melissa Hagerman EVP and Chief HR Officer | 110,930 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $6.65 per share | 737,684.50 |
| Mar 3, 2025 | Melissa Hagerman EVP and Chief HR Officer | 117,467 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 3, 2025 | Mark Blakeley Hodges EVP and Chief Risk Officer | 88,804 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 3, 2025 | Mark Blakeley Hodges EVP and Chief Risk Officer | 43,432 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 3, 2025 | Jerome T. Upton EVP & Chief Financial Officer | 421,867 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 3, 2025 | Gregory S. Karawan EVP and General Counsel | 54,289 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 3, 2025 | Mark Blakeley Hodges EVP and Chief Risk Officer | 56,259 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Gregory S. Karawan EVP and General Counsel | 315,846 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $6.65 per share | 2,100,375.90 |
| Mar 3, 2025 | Gregory S. Karawan EVP and General Counsel | 323,379 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 3, 2025 | Mark Blakeley Hodges EVP and Chief Risk Officer | 82,267 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $6.65 per share | 547,075.55 |
| Mar 3, 2025 | Samir B Shah Pres. & CEO, CareScout Svcs. | 112,518 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Jerome T. Upton EVP & Chief Financial Officer | 112,518 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Jerome T. Upton EVP & Chief Financial Officer | 86,862 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |